{"address1": "6707 Winchester Circle", "address2": "Suite 400", "city": "Boulder", "state": "CO", "zip": "80301", "country": "United States", "phone": "720 307 2892", "website": "https://onkuretherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Dr. Nicholas A. Saccomano Ph.D.", "age": 65, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 741743, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason A. Leverone CPA", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 565258, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Agresta M.D., M.P.H.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 650371, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dylan  Hartley Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rogan P. Nunn J.D.", "title": "General Counsel & Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Blake Ph.D.", "title": "Senior Vice President of Computational Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Duncan  Walker Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin S. Litwiler Ph.D.", "title": "Senior Vice President of DMPK & Clinical Pharmacology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark L. Boys Ph.D.", "title": "Senior Vice President of Discovery Chemistry", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roberta  Alton", "title": "Senior VP of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.3, "open": 4.32, "dayLow": 4.11, "dayHigh": 4.32, "regularMarketPreviousClose": 4.3, "regularMarketOpen": 4.32, "regularMarketDayLow": 4.11, "regularMarketDayHigh": 4.32, "payoutRatio": 0.0, "forwardPE": -1.3741937, "volume": 17495, "regularMarketVolume": 17495, "averageVolume": 67816, "averageVolume10days": 18540, "averageDailyVolume10Day": 18540, "bid": 4.59, "ask": 5.0, "bidSize": 1, "askSize": 1, "marketCap": 57236512, "fiftyTwoWeekLow": 4.11, "fiftyTwoWeekHigh": 19.999, "fiftyDayAverage": 5.2134, "twoHundredDayAverage": 12.1723, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -52439380, "profitMargins": 0.0, "floatShares": 4299061, "sharesOutstanding": 12749300, "sharesShort": 1097765, "sharesShortPriorMonth": 1098416, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0799, "heldPercentInsiders": 0.01568, "heldPercentInstitutions": 0.97243, "shortRatio": 30.24, "impliedSharesOutstanding": 13435800, "bookValue": 7.779, "priceToBook": 0.5476283, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -52673000, "trailingEps": -15.28, "forwardEps": -3.1, "lastSplitFactor": "1:10", "lastSplitDate": 1728259200, "enterpriseToEbitda": 0.988, "52WeekChange": -0.7508772, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 4.26, "targetHighPrice": 34.0, "targetLowPrice": 30.0, "targetMeanPrice": 32.0, "targetMedianPrice": 32.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 110761000, "totalCashPerShare": 8.244, "ebitda": -53080000, "totalDebt": 1085000, "quickRatio": 10.519, "currentRatio": 10.732, "debtToEquity": 1.045, "returnOnAssets": -0.44426, "returnOnEquity": -0.79921997, "freeCashflow": -23707376, "operatingCashflow": -51117000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OKUR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "OnKure Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_142375117", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.95339966, "fiftyDayAverageChangePercent": -0.18287484, "twoHundredDayAverageChange": -7.9123, "twoHundredDayAverageChangePercent": -0.65002507, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1617888600000, "regularMarketChange": -0.03999996, "regularMarketDayRange": "4.11 - 4.32", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 67816, "fiftyTwoWeekLowChange": 0.1500001, "fiftyTwoWeekLowChangePercent": 0.03649637, "fiftyTwoWeekRange": "4.11 - 19.999", "fiftyTwoWeekHighChange": -15.739, "fiftyTwoWeekHighChangePercent": -0.78698933, "fiftyTwoWeekChangePercent": -75.08772, "earningsTimestamp": 1741637116, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.28, "epsForward": -3.1, "epsCurrentYear": -5.16, "priceEpsCurrentYear": -0.8255815, "longName": "OnKure Therapeutics, Inc.", "regularMarketChangePercent": -0.93023163, "regularMarketPrice": 4.26, "displayName": "OnKure Therapeutics", "trailingPegRatio": null}